ClinicalTrials.Veeva

Menu

High-Sensitive CRP and Carotid Stiffness Between Patients With and Without Coronary Slow Flow

S

Sohag University

Status

Completed

Conditions

Coronary Slow Flow
Carotid Stiffness
High-sensitivity C-reactive Protein

Treatments

Diagnostic Test: High-sensitivity C-reactive protein
Other: Stiffness Measurement

Study type

Observational

Funder types

Other

Identifiers

NCT07076745
Soh-Med-25-5-6PD

Details and patient eligibility

About

This study aims to compare the levels of high-sensitivity C-reactive protein (hs-CRP) and carotid artery stiffness between patients with coronary slow flow phenomenon (CSFP) and those with normal coronary flow.

Full description

The coronary slow flow phenomenon (CSFP) is characterized by delayed opacification of the coronary arteries during angiography in the absence of significant epicardial coronary artery disease.

Hypothesis: High-sensitivity C-reactive protein (hs-CRP) is a well-established biomarker of systemic inflammation and has been associated with various cardiovascular conditions. Elevated hs-CRP levels have been observed in patients with CSFP, suggesting an inflammatory component in its pathogenesis. This marker not only predicts future cardiovascular events but may also reflect ongoing vascular inflammation in patients with angiographically normal coronary arteries.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years old.
  • Both sexes.
  • Patients undergo coronary angiography for evaluation of chest pain or suspected ischemia.

Exclusion criteria

  • Pregnant or breastfeeding women.
  • History of cardiovascular events such as myocardial infarction or stroke.
  • Diagnosed autoimmune disorders, chronic hepatic or renal diseases.
  • Current or recent infections.
  • History of malignancy.
  • Patients taking medications known to affect inflammatory markers (e.g., corticosteroids or immunosuppressants).

Trial design

60 participants in 2 patient groups

Study group
Description:
Patients diagnosed with coronary slow flow based on corrected thrombolysis in myocardial infarction (TIMI) frame count (cTFC) \>27.
Treatment:
Other: Stiffness Measurement
Diagnostic Test: High-sensitivity C-reactive protein
Control group
Description:
Patients with normal coronary angiographic flow and no obstructive coronary artery disease.
Treatment:
Other: Stiffness Measurement
Diagnostic Test: High-sensitivity C-reactive protein

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems